These findings suggest that troglitazone can mediate mitochondrial pathway‐induced tubular cell apoptosis by inhibiting ADAMTS1, thus reducing inflammation and kidney damage in I/R‐AKI model mice. This evidence concerns the gene ADAMTS1 and Nephropathy.